{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:00Z","timestamp":1786123380730,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Ergometrine is a uterotonic agent that is recommended in the prevention and management of postpartum hemorrhage. Despite its long-standing use, the mechanism by which it acts in humans has never been elucidated fully. The objective of this study was to investigate the role of adrenoreceptors in ergometrine\u2019s mechanism of action in human myometrium. The study examined the hypothesis that \u03b1-adrenoreceptor antagonism would result in the reversal of the uterotonic effects of ergometrine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Myometrial samples were obtained from women undergoing elective cesarean delivery. The samples were then dissected into strips and mounted in organ bath chambers. After the generation of an ergometrine concentration\u2013response curve (10\n                      <jats:sup>\u201315<\/jats:sup>\n                      to 10\n                      <jats:sup>\u20135<\/jats:sup>\n                      M), strips were treated with increasing concentrations of ergometrine (10\n                      <jats:sup>\u201315<\/jats:sup>\n                      to 10\n                      <jats:sup>\u20137<\/jats:sup>\n                      M) alone and ergometrine (10\n                      <jats:sup>\u20137<\/jats:sup>\n                      to 10\n                      <jats:sup>\u20135<\/jats:sup>\n                      M) in the presence of phentolamine (10\n                      <jats:sup>\u20137<\/jats:sup>\n                      M), prazosin (10\n                      <jats:sup>\u20137<\/jats:sup>\n                      M), propranolol (10\n                      <jats:sup>\u20136<\/jats:sup>\n                      M), or yohimbine (10\n                      <jats:sup>\u20136<\/jats:sup>\n                      M). The effects of adding ergometrine and the effect of drug combinations were analyzed using linear mixed effects models with measures of amplitude (g), frequency (contractions\/10 min), and motility index (g\u00d7contractions\/10 min).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 157 experiments were completed on samples obtained from 33 women. There was a significant increase in the motility index (adding 0.342 g \u00d7 counts\/10 min\/\u03bcM; 95% confidence interval [CI], 0.253\u20130.431,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), amplitude (0.078 g\/\u03bcM; 95% CI, 0.0344\u20130.121,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 5e-04), and frequency (0.051 counts\/10 min\/\u03bcM; 95% CI, 0.038\u20130.063,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) in the presence of ergometrine. The \u03b1-adrenergic antagonist phentolamine and the more selective \u03b1\n                      <jats:sub>1<\/jats:sub>\n                      -adrenergic antagonist prazosin inhibited the ergometrine mediated increase in motility index, amplitude, and frequency (\u22121.63 g \u00d7 counts\/10 min\/\u03bcM and \u221216.70 g \u00d7 counts\/10 min\/\u03bcM for motility index, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>These results provide novel evidence for a role for \u03b1-adrenergic signaling mechanisms in the action of ergometrine on human myometrial smooth muscle in the in vitro setting. Information that sheds light on the mechanism of action of ergometrine may have implications for the development of further uterotonic agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000001765","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T14:42:32Z","timestamp":1487256152000},"page":"1581-1588","source":"Crossref","is-referenced-by-count":18,"title":["A Role for Adrenergic Receptors in the Uterotonic Effects of Ergometrine in Isolated Human Term Nonlaboring Myometrium"],"prefix":"10.1213","volume":"124","author":[{"given":"Rebecca A.","family":"Fanning","sequence":"first","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florike","family":"Sheehan","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Leyden","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Duffy","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Iglesias-Martinez","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Carey","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre P.","family":"Campion","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.semperi.2008.12.001","article-title":"Uterine atony: definition, prevention, nonsurgical management, and uterine tamponade.","volume":"33","author":"Breathnach","year":"2009","journal-title":"Semin Perinatol"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1213\/ANE.0b013e3181d74898","article-title":"The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries.","volume":"110","author":"Bateman","year":"2010","journal-title":"Anesth Analg"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2393-9-55","article-title":"Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group.","volume":"9","author":"Knight","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"63.e1","DOI":"10.1016\/j.ajog.2011.07.030","article-title":"Peripartum hysterectomy in the United States: nationwide 14 year experience.","volume":"206","author":"Bateman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1471-0528.2011.03198.x","article-title":"Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study.","volume":"119","author":"Lutomski","year":"2012","journal-title":"BJOG"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1701-2163(16)34984-2","article-title":"Risk factors for postpartum hemorrhage: can we explain the recent temporal increase?","volume":"33","author":"Kramer","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1471-0528.2007.01316.x","article-title":"Investigation of an increase in postpartum haemorrhage in Canada.","volume":"114","author":"Joseph","year":"2007","journal-title":"BJOG"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijgo.2007.03.011","article-title":"Increased postpartum hemorrhage rates in Australia.","volume":"98","author":"Ford","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/01443610701667411","article-title":"Ergometrine given during caesarean section and incidence of delayed postpartum haemorrhage due to uterine atony.","volume":"27","author":"Lourens","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"353.e1","DOI":"10.1016\/j.ajog.2010.01.011","article-title":"Trends in postpartum hemorrhage: United States, 1994-2006.","volume":"202","author":"Callaghan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230721","first-page":"CD001808","article-title":"Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.","volume":"10","author":"Westhoff","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-20230721","first-page":"1039","article-title":"ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage.","volume":"108","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12630-014-0190-1","article-title":"Comparative efficacy of uterotonic agents: in vitro contractions in isolated myometrial strips of labouring and non-labouring women.","volume":"61","author":"Balki","year":"2014","journal-title":"Can J Anaesth"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1213\/ANE.0000000000000682","article-title":"The contractile effects of oxytocin, ergonovine, and carboprost and their combinations: an in vitro study on human myometrial strips.","volume":"120","author":"Balki","year":"2015","journal-title":"Anesth Analg"},{"key":"R17-20230721","first-page":"315","article-title":"Uterine contractility patterns of the outer and inner zones of the myometrium.","volume":"44","author":"Daels","year":"1974","journal-title":"Obstet Gynecol"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000298771","article-title":"Adrenergic receptors in inner and outer layers of human myometrium near term: characterization of beta-adrenergic receptor sites by [125I]-iodocyanopindolol binding.","volume":"24","author":"Breuiller","year":"1987","journal-title":"Gynecol Obstet Invest"},{"key":"R19-20230721","first-page":"523","article-title":"Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.","volume":"56","author":"de Groot","year":"1998","journal-title":"Drugs"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1213\/ANE.0b013e3181ea5f77","article-title":"Spinal hypotension during elective cesarean delivery: closer to a solution.","volume":"111","author":"Dyer","year":"2010","journal-title":"Anesth Analg"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1213\/ane.0b013e3181804245","article-title":"A comparison of the inhibitory effects of bupivacaine and levobupivacaine on isolated human pregnant myometrium contractility.","volume":"107","author":"Fanning","year":"2008","journal-title":"Anesth Analg"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/1097-0258(20000715)19:13<1793::AID-SIM482>3.0.CO;2-Q","article-title":"Modelling covariance structure in the analysis of repeated measures data.","volume":"19","author":"Littell","year":"2000","journal-title":"Stat Med"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(83)90133-4","article-title":"Interaction of ergot alkaloids and their combination (co-dergocrine) with alpha-adrenoceptors in the CNS.","volume":"93","author":"Markstein","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0028-2243(75)90059-3","article-title":"Intermittent low-dose administration of prostaglandins intraamniotically in pathological pregnancies. A comparison with oxytocin and ergometrine.","volume":"5","author":"de Koning Gans","year":"1975","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00016348709020754","article-title":"The effect of labetalol on contractility of human myometrial preparations.","volume":"66","author":"Thulesius","year":"1987","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000293327","article-title":"Effect of methylergometrine maleate (methergin) on electrical and mechanical activities of pregnant human myometrium.","volume":"29","author":"Kawarabayashi","year":"1990","journal-title":"Gynecol Obstet Invest"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.2042-7158.1988.tb05200.x","article-title":"Agonist profile of ergometrine (ergonovine) on a population of postsynaptic alpha-adrenoceptors.","volume":"40","author":"Gibson","year":"1988","journal-title":"J Pharm Pharmacol"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/ALN.0b013e318297d347","article-title":"Oxytocin pretreatment attenuates oxytocin-induced contractions in human myometrium in vitro.","volume":"119","author":"Balki","year":"2013","journal-title":"Anesthesiology"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1213\/ANE.0000000000000398","article-title":"Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011.","volume":"119","author":"Bateman","year":"2014","journal-title":"Anesth Analg"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2014.05.037","article-title":"The influence of smooth muscle content and orientation in dissected human pregnant myometrial strips on contractility measurements.","volume":"738","author":"Crankshaw","year":"2014","journal-title":"Eur J Pharmacol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201705000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:23:19Z","timestamp":1786112599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201705000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000001765","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}